BioMarin Pharmaceutical, Inc. United States of America (USA)
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for BioMarin Pharmaceutical, Inc. published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
2 | 1.02 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 2 | 1.02 |
Chemistry | 1 | 1.00 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 1.29 | 0.17 | 1.38 | 0.94 |
Compare BioMarin Pharmaceutical, Inc. with other institutions
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 58.00% Domestic
- 42.00% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with BioMarin Pharmaceutical, Inc. by Share (4 total)
-
BioMarin Pharmaceutical, Inc. and Mayo Clinic
(0.21)
-
BioMarin Pharmaceutical, Inc. and Sage Bionetworks
(0.21)
-
BioMarin Pharmaceutical, Inc. and Biogen Inc.
(0.19)
-
BioMarin Pharmaceutical, Inc. and Columbia University in the City of New York (CU)
(0.07)
Top 10 international collaborators with BioMarin Pharmaceutical, Inc. by Share (3 total)
-
BioMarin Pharmaceutical, Inc. and University of Bristol (UoB)
(0.38)
-
BioMarin Pharmaceutical, Inc. and NIHR Bristol Biomedical Research Centre (Bristol BRC)
(0.07)
-
BioMarin Pharmaceutical, Inc. and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW NHS)
(0.05)
Relationships
BioMarin Pharmaceutical, Inc.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.